An unmodified,
full length rFVIII1
The potential for as few
as 2 infusions per week1
EXPLORE 
what's possible
IMPORTANT SAFETY INFORMATION INDICATIONS

For additional important risk and use information, click here for full Prescribing Information.

You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.

rFVIII=recombinant Factor VIII.

Reference: 1. KOVALTRY® [prescribing information]. Whippany, NJ: Bayer HealthCare LLC; 2016.

Bayer Logo

Bayer, the Bayer Cross, and KOVALTRY are registered trademarks of Bayer.

© 2016 Bayer. All rights reserved.
07/16PP-675-US-0528